← Evidence map

ArticleEndocrine2002

Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells.

Philip Zeitler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2002

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this papercites it

Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells. | OpenQuestion